Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
LIMN
LNAI
Add up to 3 more stocks
LIMN
Liminatus Pharma, Inc. Class A Common Stock
-4.51%
$3.81-0.18Delayed quote: Oct 6, 2026, 2:13 PM EDT
Market Cap
$5.12M
52W Range
$3.29 - $141.50
LNAI
Lunai Bioworks Inc.
+0.88%
$1.15+0.01Delayed quote: Oct 6, 2026, 2:13 PM EDT
Market Cap
$5.21M
52W Range
$1.13 - $13.28
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 17.02 | N/A |
| P/S Ratio | N/A | 248.97 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | -612568.1% |
| ROE | -4165.9% | N/A |
| ROA | -367.9% | -1301.0% |
| ROIC | -225.1% | N/A |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.12 | 0.19 |
| Quick Ratio | 1.12 | 0.19 |
| Debt/Equity | 4.80 | N/A |
| Interest Coverage | -13.75 | -25.56 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.